Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population

Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population

Purpose: To describe the characteristics of myopic choroidal neovascular membranes of hispanic subjects treated with a loading dose of Ranibizumab (Lucentis®). Study design: Non-randomized prospective observational case study. Methods: Five eyes of 5 patients with naïve CNV secondary to pathological...

Full description

Bibliographic Details
Main Authors: Hernan Andres Rios, Anne Brieke, Shirley Rosenstiehl, Francisco Rodriguez
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:The Pan-American Journal of Ophthalmology
Subjects:
myopic choroidal neovascular membrane
ranibizumab
hispanic population.
Online Access:http://www.thepajo.org/article.asp?issn=2666-4909;year=2017;volume=16;issue=2;spage=43;epage=45;aulast=Rios;type=0

Internet

http://www.thepajo.org/article.asp?issn=2666-4909;year=2017;volume=16;issue=2;spage=43;epage=45;aulast=Rios;type=0

Similar Items